VTVT
vTv Therapeutics·NASDAQ
--
--(--)
--
--(--)
4.25 / 10
Netural
Fund flow analysis scores 7.14/10, indicating robust fund flow characteristics. Bullish trends in overall, block, Medium, and Extra-large contrast with bearish signals in Small and Large, suggesting positive liquidity momentum. Analyst coverage indicates overwhelmingly bullish analyst consensus with strong conviction. Rating distribution: Strong Buy(100.0%) among 2 analysts, supported by 1.37 historical weighted rating.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-01-23
InstitutionRoth Capital
Times predicted1
Historical Win Rate0.0%
What is the analyst consensus for VTVT?
- VTVT holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 4.25/10 (Netural).
